StonvexLoading…
StonvexStonvexStonvexCore line items from SBFM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $8.09M | $36.31M | $27.73M | $18.31M |
Operating Income | $-1.40M | $-6.23M | $-4.44M | $-3.35M |
Net Income | $-1.24M | $-5.98M | $-3.83M | $-2.95M |
EPS (Diluted) | $-0.25 | $-1.44 | $-0.98 | $-0.82 |
Total Assets | $27.93M | $30.08M | $31.49M | $31.97M |
Total Liabilities | $6.41M | $7.04M | $7.29M | $6.28M |
Cash & Equivalents | $6.91M | $9.12M | $9.31M | $10.31M |
Free Cash Flow OCF − CapEx | $-2.08M | $-5.51M | $-3.89M | $-3.15M |
Shares Outstanding | 4.91M | 4.91M | 4.56M | 4.56M |